• europages
  • >
  • COMPANIES - SUPPLIERS - SERVICE PROVIDERS
  • >
  • market intelligence

Results for

Market intelligence

GermanyStuttgart, Freiburg and Baden-WurtembergManufacturer/producer
  1. ANDREAS MAIER GMBH & CO. KG (AMF)

    Germany

    Andreas Maier Fellbach (AMF), originally founded in 1890, today is a one-stop supplier in clamping technology and is one of the world market leaders. With a global market presence, the company and its employees always have an open ear for the problems of their customers. By listening to these needs, and through its strong problem-solving ability, professional consultancy, intelligent engineering and high manufacturing quality, AMF repeatedly develops project fabrications and customised solutions for customers as well as standard solutions that succeed in the market again. With more than 5, 000 products and numerous patents, it ranks among the top innovators in the industry. Speed, flexibility and 230 well-qualified employees guarantee success at Andreas Maier GmbH & Co. KG. In 2018, AMF earned revenue of more than 50 million euros for the first time.

  2. ATG:BIOSYNTHETICS GMBH

    Germany

    ATG: biosynthetics is a synthetic biology company located in Merzhausen near Freiburg. We are experts in combinatorial gene design and multi-gene expression and offer multi-gene and multi-peptide expression products and services for R&D: • Multi-protein recombineering and expression systems for E.coli, insect and mammalian cells + tailor-made expression systems for other (micro)organisms• Multi-peptide library design tool as well as multi-peptide library construction and expression system (PepID)• Gene intelligence solution EvoMAG for multi-parametric gene / gene cluster design and optimization in diverse target organisms (metabolic engineering, etc.)• Gene synthesis of individual genes and gene clusters• Synthetic biology projecting and consulting from design to (multi-gene) expression strategy ATG also looks for strategic partnerships and outsourcing projects that aim at developing and marketing high-potential applications, e.g. DNA- and protein based vaccines.